XBIO Financials
Xenetic Biosciences Inc - Financial statements & key metrics
Stock Price
$4.23
Market Cap
$5.71M
P/E Ratio
-1.6
EPS
$-2.57
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.50M
Gross Profit
-
Operating Income
-
Net Income
$-3.96M
EPS (Diluted)
$-2.57
Balance Sheet Highlights
Total Assets
$6.90M
Total Liabilities
$894,263
Shareholders Equity
-
Cash & Equivalents
$6.17M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-2.82M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-158.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is XBIO revenue?
XBIO's most recent quarterly revenue was $2.50M. Annual revenue can be calculated by summing the four most recent quarters.
Is XBIO profitable?
XBIO reported a loss of $3.96M in the most recent quarter. The net profit margin is -158.4%.
What is XBIO market cap?
XBIO has a market capitalization of $5.71M, making it a small-cap stock.
Does XBIO have debt?
View XBIO's balance sheet for debt information.
What is XBIO cash flow?
Cash flow data is available in the full financial statements.